Metformin study for prostate cancer patients with weight or sugar issues
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This early-phase study tests whether metformin can help prostate cancer patients who have higher body weight and/or early blood sugar problems. You would be screened for eligibility using your medical record, and the study looks mainly at your current health factors and medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man age 18 or older and sign the consent form in your patient portal or in Epic
- Have a prostate cancer diagnosis
- Have a UCHealth care relationship with a participating provider
- In the last year, have either early blood sugar elevation (A1c 5.7% to 6.4%) and/or higher body weight (BMI 25 or more)
- Not currently take metformin or other diabetes medicines that list on the study as excluded (insulin, many pills, and diabetes injections)
- Have no reason metformin would be unsafe for you (such as kidney function too low, certain liver problems, or a known metformin allergy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if metformin, a common diabetes medicine, can help reduce insulin resistance in women who finished chemotherapy for early-stage breast cancer. It aims to improve long-term health and prevent future problems.
This trial tests if adding metformin, a common diabetes drug, to standard chemotherapy or immunotherapy can help treat advanced solid tumors. It may be an option for people who are already eligible for chemo or immunotherapy.
This trial studies whether a diabetes medicine called metformin can help prevent or control non-muscle-invasive bladder cancer inside the bladder. You would take it by mouth, and the study checks safety and whether it works.
This Phase 2 study tests whether taking metformin after surgery and chemotherapy can reduce the risk of bone cancer coming back in people at high risk of relapse. You may be eligible if you have osteosarcoma or Ewing sarcoma that is not currently spread and you meet specific lab and health criteria.
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
This study aims to find different types of diabetes risk and test which prevention methods work best for each type. Researchers will use detailed health measurements to understand the causes of diabetes.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.